179 related articles for article (PubMed ID: 26591311)
1. [Colorectal cancer: ten years of illusion of progress but advances are on the horizon].
Shaza L; Charette N; Hendlisz A
Rev Med Brux; 2015 Sep; 36(4):263-6. PubMed ID: 26591311
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of targeted therapy with cetuximab in patients with K-ras wild-type colorectal cancer presenting with initially unresectable metastases limited to the liver in a German setting.
Asseburg C; Frank M; Köhne CH; Hartmann JT; Griebsch I; Mohr A; Osowski U; Schulten J; Mittendorf T
Clin Ther; 2011 Apr; 33(4):482-97. PubMed ID: 21635994
[TBL] [Abstract][Full Text] [Related]
3. [Progress in adjuvant and palliative chemotherapy of colorectal cancer: current status and perspectives].
Scheithauer W
Wien Klin Wochenschr; 1993; 105(20):568-79. PubMed ID: 7505075
[TBL] [Abstract][Full Text] [Related]
4. Neoadjuvant and adjuvant therapy in relation to surgery for colorectal liver metastases.
Brouquet A; Nordlinger B
Scand J Gastroenterol; 2012 Mar; 47(3):286-95. PubMed ID: 22182353
[TBL] [Abstract][Full Text] [Related]
5. Safety, tolerability, and efficacy of oxaliplatin-based adjuvant chemotherapy after curative resection of hepatic or extrahepatic metastases of Stage IV colorectal cancer.
Nakayama I; Suenaga M; Wakatsuki T; Ichimura T; Ozaka M; Takahari D; Shinozaki E; Chin K; Ueno M; Mizunuma N; Yamaguchi T
Cancer Chemother Pharmacol; 2015 Jul; 76(1):133-9. PubMed ID: 25994854
[TBL] [Abstract][Full Text] [Related]
6. Chemotherapy of metastatic colorectal cancer.
Prescrire Int; 2010 Oct; 19(109):219-24. PubMed ID: 21180382
[TBL] [Abstract][Full Text] [Related]
7. Current opinion on optimal systemic treatment for metastatic colorectal cancer: outcome of the ACTG/AGITG expert meeting ECCO 2013.
Price TJ; Segelov E; Burge M; Haller DG; Tebbutt NC; Karapetis CS; Punt CJ; Pavlakis N; Arnold D; Gibbs P; Shapiro JD
Expert Rev Anticancer Ther; 2014 Dec; 14(12):1477-93. PubMed ID: 25138900
[TBL] [Abstract][Full Text] [Related]
8. [Progress of adjuvant chemotherapy in colon cancer].
Toge T
Gan To Kagaku Ryoho; 1996 Apr; 23(5):554-9. PubMed ID: 8678512
[TBL] [Abstract][Full Text] [Related]
9. Clinical impact of K-ras mutation in colorectal cancer patients treated with adjuvant FOLFOX.
Chang MH; Lee IK; Si Y; Lee KS; Woo IS; Byun JH
Cancer Chemother Pharmacol; 2011 Aug; 68(2):317-23. PubMed ID: 20972872
[TBL] [Abstract][Full Text] [Related]
10. [The present situation regarding postoperative adjuvant chemotherapy].
Shimada R; Nozawa K; Watanabe T
Gan To Kagaku Ryoho; 2011 Sep; 38(9):1396-402. PubMed ID: 21918334
[TBL] [Abstract][Full Text] [Related]
11. [Recent advances is surgical adjuvant chemotherapy for colorectal cancer].
Kodaira S; Shatari T; Nozawa K
Gan To Kagaku Ryoho; 2000 Dec; 27(14):2201-8. PubMed ID: 11142163
[TBL] [Abstract][Full Text] [Related]
12. New drugs and combinations in the palliative treatment of colon and rectal cancer.
Beretta GD; Pessi MA; Poletti P; Mosconi S; Labianca R
Eur J Surg Oncol; 2001 Sep; 27(6):595-600. PubMed ID: 11520095
[TBL] [Abstract][Full Text] [Related]
13. [Therapy of colorectal carcinoma in internal medicine].
Graeven U; Schmiegel W
Praxis (Bern 1994); 2002 Oct; 91(43):1797-805. PubMed ID: 12432692
[TBL] [Abstract][Full Text] [Related]
14. Adjuvant systemic chemotherapy with or without bevacizumab in patients with resected liver metastases from colorectal cancer.
Turan N; Benekli M; Koca D; Ustaalioglu BO; Dane F; Ozdemir N; Ulas A; Oztop I; Gumus M; Ozturk MA; Berk V; Kucukoner M; Uner A; Balakan O; Helvaci K; Ozkan S; Yilmaz U; Buyukberber S;
Oncology; 2013; 84(1):14-21. PubMed ID: 23076023
[TBL] [Abstract][Full Text] [Related]
15. [The clinical outcome of mFOLFOX6 treatment for colorectal cancer patients who underwent resection of liver metastasis -comparison between synchronous and metachronous liver metastasis].
Honjou H; Ishibashi K; Okada N; Tajima Y; Ishiguro T; Kuwabara K; Ohsawa T; Kumamoto K; Tsuji Y; Haga N; Iwama T; Ishida H
Gan To Kagaku Ryoho; 2011 Nov; 38(12):2216-9. PubMed ID: 22202335
[TBL] [Abstract][Full Text] [Related]
16. [Current aspects of adjuvant and palliative chemotherapy in colorectal carcinoma].
Bokemeyer C; Hartmann JT; Kanz L
Praxis (Bern 1994); 1997 Sep; 86(39):1510-6. PubMed ID: 9411671
[TBL] [Abstract][Full Text] [Related]
17. [Advances in the treatment of colorectal cancer].
Maehara Y; Ohno S; Tomisaki S; Kakeji Y; Watanabe A; Baba H; Adachi Y; Ichiyoshi Y; Korenaga D; Sugimachi K
Gan To Kagaku Ryoho; 1996 Apr; 23(5):517-28. PubMed ID: 8678508
[TBL] [Abstract][Full Text] [Related]
18. Epidermal growth factor receptor: pathway, therapies, and pipeline.
Goffin JR; Zbuk K
Clin Ther; 2013 Sep; 35(9):1282-303. PubMed ID: 24054705
[TBL] [Abstract][Full Text] [Related]
19. Potentially resectable metastatic colorectal cancer: an individualized approach to conversion therapy.
Marino D; Leone F; D'Avanzo F; Ribero D; Capussotti L; Aglietta M
Crit Rev Oncol Hematol; 2014 Dec; 92(3):218-26. PubMed ID: 24985058
[TBL] [Abstract][Full Text] [Related]
20. Chemotherapy of nonoperable colorectal liver metastases.
Piedbois P; Zelek L; Cherqui D
Hepatogastroenterology; 2001; 48(39):711-4. PubMed ID: 11462909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]